Is the С-reactive protein/albumin ratio a prognostic factor in children with peripheral facial paralysis?

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Bell’s Palsy (BP), accepted as an idiopathic condition and for which inflammation is believed to have a role in the pathogenesis, is a disease characterized by acute unilateral weakness in facial muscles innervated by the facial nerve.

AIM: This study aimed to examine the relationship between the C-reactive protein/albumin ratio (CAR) and hematological parameters including the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV), and red cell distribution width (RDW) in children with BP.

MATERIALS AND METHODS: The study included 65 children diagnosed with idiopathic peripheral facial paralysis and a control group of 49 healthy children. The patients were classified into two groups according to the House-Brackmann (HB) grade at the time of diagnosis, as mild (HB grade 2–3) and severe (HB grade 4–5). Patients evaluated as HB grade 1 with normal, healthy, and symmetrical muscle function were not included in the study. The children in the patient group were classified into three groups at the end of a six-month follow-up period as full recovery, partial recovery, and no recovery. The patient and control groups were compared according to the CAR, NLR, PLR, MPV, and RDW values. After treatment, the full recovery and no recovery groups were compared based on the CAR, NLR, PLR, MPV, and RDW values.

RESULTS: The NLR was found to be significantly higher in the BP patient group than in the control group (p <0.001). There was also a significant difference in the NLR value between the full recovery and no recovery groups. No statistically significant difference was found between the patient and control groups or between the full recovery and no recovery groups in terms of the CAR, PLR, MPV and RDW values.

CONCLUSIONS: NLR, an easily accessed hematological parameter, may be used as a marker of poor prognosis in pediatric patients with BP. CAR was of no prognostic value in pediatric BP patients.

Full Text

Restricted Access

About the authors

Muhammed Ayral

Dicle University

Author for correspondence.
Email: drayral@hotmail.com
ORCID iD: 0000-0002-2421-4842

research associate, Department of Otorhinolaryngology

Turkey, Diyarbakir

Serdar Ferit Toprak

Dicle University

Email: serdarferit@yahoo.com
ORCID iD: 0000-0003-3879-8794

research associate, Department of Otorhinolaryngology

Turkey, Diyarbakir

Serhat Samanci

Diyarbakir Child Hospital

Email: samanciserhat@hotmail.com
ORCID iD: 0000-0001-9385-132X

MD, Cand. Sci. (Med.), Clinic of Pediatrics

Turkey, Çocuk Hastalıkları Hastanesi, Yenişehir/Diyarbakır, 21100

Serkan Dedeoglu

University of Health Sciences Gazi Yasargil Training and Research Hospital, Department of Otorhinolaryngology

Email: drserkandedeoglu@gmail.com
ORCID iD: 0000-0001-6276-8355

research associate

Turkey, Diyarbakir

References

  1. ttb.org [Internet]. Ünüvar E., Fatih Aydın F., Özmen M., Çocukluk Döneminde idiyopatik Fasiyal Paralizi [cited 06 January 2022]. Available from: https://www.ttb.org.tr/STED/sted0702/bell.pdf.
  2. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002(549):4–30.
  3. Evans AK, Licameli G, Brietzke S, et al. Pediatric facial nerve paralysis: patients, management and outcomes. Int J Pediatr Otorhinolaryngol. 2005;69(11):1521–1528. doi: 10.1016/j.ijporl.2005.04.025
  4. Sayın İ, Yazıcı ZM, Yarar Ç, Erdim İ, et al. Çocuklarda İdyopatik Fasiyal Paralizi. Medical Journal of Bakırköy. 2012;8(3).
  5. Susaman N, Yıldırım YSS. Kliniğimizde Bell Paralizisi Tanısı Alan Hastaların Retrospektif Analizi. KBB-Forum. 2020;19(1):34–38.
  6. de Almeida JR, Guyatt GH, Sud S, et al. Management of Bell palsy: clinical practice guideline. CMAJ. 2014;186(12):917–922. doi: 10.1503/cmaj.131801
  7. Ferroni P, Riondino S, Formica V, et al. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer. 2015;136(5):1234–1240. doi: 10.1002/ijc.29076
  8. Nonoyama H, Tanigawa T, Shibata R, et al. Red blood cell distribution width predicts prognosis in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 16;136(11):1137–1140. doi: 10.1080/00016489.2016.1195919
  9. Oya R, Takenaka Y, Imai T, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Hematologic Markers of Bell's Palsy: A Meta-analysis. Otol Neurotol. 2019;40(5):681–687. doi: 10.1097/MAO.0000000000002166
  10. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin. 2003;21(3):315-325. doi: 10.1016/s0733–8651(03)00079-1
  11. Artigas A, Wernerman J, Arroyo V, et al. Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care. 2016;33:62–70. doi: 10.1016/j.jcrc.2015.12.019
  12. Zhou D, Zhang P, Bao C, et al. Emerging Understanding of Etiology and Epidemiology of the Novel Coronavirus (COVID-19) infection in Wuhan, China. Preprints. 2020. 2020020283. doi: 10.20944/PREPRINTS202002.0283.V1
  13. Miyamoto T, Fujitani M, Fukuyama H, et al. The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients. J Palliat Med. 2019;22(5):532–537. doi: 10.1089/jpm.2018.0404
  14. Ranzani OT, Zampieri FG, Forte DN, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8(3):e59321. doi: 10.1371/journal.pone.0059321
  15. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93(2):146–147. doi: 10.1177/019459988509300202
  16. Jenke AC, Stoek LM, Zilbauer M, et al. Facial palsy: etiology, outcome and management in children. Eur J Paediatr Neurol. 2011;15(3):209–213. doi: 10.1016/j.ejpn.2010.11.004
  17. Furuta Y, Fukuda S, Chida E, et al. Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J Med Virol. 1998;54(3):162–166. doi: 10.1002/(sici)1096-9071(199803)54:3<162::aid-jmv3>3.0.co;2-3
  18. Babl FE, Mackay MT, Borland ML, et al. Bell's Palsy in Children (BellPIC): protocol for a multicentre, placebo-controlled randomized trial. BMC Pediatr. 2017;17(1):53. doi: 10.1186/s12887-016-0702-y
  19. Yariv O, Popovtzer A, Wasserzug O, et al. Usefulness of ultrasound and fine needle aspiration cytology of major salivary gland lesions. Am J Otolaryngol. 2020;41(1):102293. doi: 10.1016/j.amjoto.2019.102293
  20. Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1 Pt 1):27–30. doi: 10.7326/0003-4819-124-1_part_1-199601010-00005
  21. Cawthorne T. The pathology and surgical treatment of Bell's palsy. Proc R Soc Med. 1951;44(7):565–572. PMC2081824
  22. Yetiser S, Kazkayas M, Altinok D, Karadeniz Y. Magnetic resonance imaging of the intratemporal facial nerve in idiopathic peripheral facial palsy. Clin Imaging. 2003;27(2):77–81. doi: 10.1016/s0899-7071(02)00485-0
  23. Kum RO, Yurtsever Kum N, Ozcan M, et al. Elevated neutrophil-to-lymphocyte ratio in Bell's palsy and its correlation with facial nerve enhancement on MRI. Otolaryngol Head Neck Surg. 2015;152(1):130–135. doi: 10.1177/0194599814555841
  24. Michaels L. Histopathological changes in the temporal bone in Bell's palsy. Acta Otolaryngol Suppl. 1990;470:114–117; discussion 118. doi: 10.3109/00016488909138364
  25. Aksakal C, Katar M. Çocuklardaki Bell’s Palsy De Nötrofil/ Lenfosit Orani, Platelet/Lenfosit Orani Ve Ortalama Trombosit Hacminin Değerlendirilmesi. Bozok Tıp Dergisi. 2019;9(3):39-44.
  26. Eryilmaz A, Basal Y, Tosun A, et al. The neutrophil to lymphocyte ratios of our pediatric patients with Bell’s palsy. International Journal of Pediatric Otorhinolaryngology. 2015;79(12):2374–2377.
  27. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754
  28. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437. doi: 10.1111/j.0894-0959.2004.17603.x
  29. Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond). 2009;9(1):30–33. doi: 10.7861/clinmedicine.9-1-30
  30. Cayir S, Hizli O, Kayabasi S. Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell’s palsy? Eur Arch Otorhinolaryngol. 2020;277(1):115–119. doi: 10.1007/s00405-019-05691-3
  31. Zheng C, Liu S, Feng J, Zhao X. Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma. Cancer Manag Res. 2020;12:2415–2425. doi: 10.2147/CMAR.S245622
  32. Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;28(3):235–243. doi: 10.1007/s00134-002-1209-6
  33. Bai M, Wu Y, Ji Z, et al. Prognostic value of C-reactive protein/albumin ratio in neurocritically ill patients. Minerva Anestesiol. 2019;85(12):1299–1307. doi: 10.23736/S0375-9393.19.13625-5
  34. Deng TB, Zhang J, Zhou YZ, Li WM. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer. Medicine (Baltimore). 2018;97(50):e13505. doi: 10.1097/MD.0000000000013505
  35. Cui X, Jia Z, Chen D, et al. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis. Medicine (Baltimore). 2020;99(14):e19165. doi: 10.1097/MD.0000000000019165
  36. Karatoprak E, Yilmaz S. Prognostic Factors Associated With Recovery in Children With Bell’s Palsy. J Child Neurol. 2019;34(14):891–896. doi: 10.1177/0883073819865672
  37. Psillas G, Antoniades E, Ieridou F, Constantinidis J. Facial nerve palsy in children: A retrospective study of 124 cases. J Paediatr Child Health. 2019;55(3):299–304. doi: 10.1111/jpc.14190
  38. Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335–344. doi: 10.1111/joim.13089
  39. Wolfovitz A, Yehudai N, Luntz M. Prognostic factors for facial nerve palsy in a pediatric population: A retrospective study and review. Laryngoscope. 2017;127(5):1175–1180. doi: 10.1002/lary.26307
  40. Atan D, Ikinciogullari A, Koseoglu S, et al. New Predictive Parameters of Bell's Palsy: Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio. Balkan Med J. 2015;32(2):167–170. doi: 10.5152/balkanmedj.2015.15456
  41. Toprak C, Tabakci MM, Simsek Z, et al. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Postepy Kardiol Interwencyjnej. 2015;11(4):288–297. doi: 10.5114/pwki.2015.55599
  42. Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis. 2015;7(10):E402–411. doi: 10.3978/j.issn.2072-1439.2015.10.04
  43. Eytan DF, Yin LX, Maleki Z, et al. Utility of preoperative fine needle aspiration in parotid lesions. Laryngoscope. 2018;128(2):398–402. doi: 10.1002/lary.26776
  44. Kim DH, Oh JH, Kim J, et al. Predictive Values of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Other Prognostic Factors in Pediatric Patients With Bell's Palsy. Ear Nose Throat J. 2021;100(10):720–725. doi: 10.1177/0145561320922097
  45. Bucak A, Ulu S, Oruc S, et al. Neutrophil-to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope. 2014;124(7):1678–1681. doi: 10.1002/lary.24551
  46. Wasano K, Kawasaki T, Yamamoto S, et al. Pretreatment Hematologic Findings as Novel Predictive Markers for Facial Palsy Prognosis. Otolaryngol Head Neck Surg. 2016;155(4):581–587. doi: 10.1177/0194599816646552

Supplementary files

Supplementary Files
Action
1. Fig. 1. Comparison of the NLR values between the groups.

Download (24KB)
2. Fig. 2. Comparison of the NLR values at the time of diagnosis.

Download (33KB)

Copyright (c) 2021 Eco-Vector



Свидетельство о регистрации СМИ № 01016 от 19.07.1995 г. выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор). 
Свидетельство о регистрации СМИ ЭЛ № ФС 77 - 80632 от 15.03.2021 г. выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies